What are the three types of mat?

Understanding Medications for Opioid Use Disorder

When it comes to treating opioid use disorder (OUD), medication can be a lifeline. The U.S. Food and Drug Administration (FDA) has approved three main medications: methadone, buprenorphine, and naltrexone. Together, they’re often referred to as medications for addiction treatment (MAT)—a cornerstone of recovery for many.

Methadone and buprenorphine work in a similar way: they ease withdrawal symptoms and reduce cravings by acting on the same brain receptors as opioids, but without producing the same high. Methadone has been used for decades and is typically dispensed in tightly regulated clinics. Buprenorphine, on the other hand, can be prescribed in office-based settings, making it more accessible. Often combined with naloxone (as in Suboxone), it lowers the risk of misuse.

Then there’s naltrexone, which functions differently. Instead of calming cravings, it blocks the effects of opioids entirely. If someone takes opioids while on naltrexone, they won’t feel the usual euphoria. This can help break the cycle of dependence, but it requires full detoxification before starting—otherwise, it can trigger sudden withdrawal.

Each medication suits different needs and lifestyles. The choice isn’t one-size-fits-all; it depends on a person’s history, support system, and treatment goals. What’s clear is that these medications, when paired with counseling and support, significantly improve long-term recovery outcomes.

Despite their effectiveness, stigma and access barriers still exist. Many people hesitate to seek MAT because of misconceptions—that using medication is just “replacing one drug with another.” But in reality, these treatments are evidence-based, medically sound, and lifesaving. With the right support, recovery is not just possible—it’s within reach.